REDWOOD CITY, Calif., June 10, 2021 /PRNewswire/ — GenapSys, Inc. (GenapSys), an organization creating a extremely correct and scalable digital sequencing platform, at the moment introduced the appointment of Fredrik Eliasson, Diana McKenzie, and Loretta Cecil to its Board of Directors.
“I am delighted to welcome our new Board members during this exciting phase of transformation and growth for GenapSys,” stated Jason Myers, Ph.D., Chief Executive Officer of GenapSys. “Over the past year, we have positioned the Company for execution and success with a proven leadership team that supports our product development plans. We are confident the collective qualifications and unique insights from Fredrik, Diana, and Loretta will be invaluable assets to advance our mission to provide an affordable, scalable genomic sequencing ecosystem for researchers and clinicians.”
“I am excited to join GenapSys as the Company’s goals align with my passion to transform healthcare through technology that provides accessible genomic sequencing,” commented Diana McKenzie. “Next-generation sequencing holds tremendous promise and GenapSys is pioneering a unique approach with an aspiration to unlock its full potential. I look forward to working with this team of talented and accomplished industry veterans and leveraging my experience to help the Company advance their next-generation sequencing platform vision.”
Diana McKenzie brings over thirty years of management expertise gained from rising and scaling international companies within the Life Sciences and Software Industry. Ms. McKenzie is the previous chief info officer for Workday, Inc. Previously, she was the chief info officer at Amgen Inc. Prior to becoming a member of Amgen, Ms. McKenzie served for 17 years at Eli Lilly and Company in a spread of IT management and cross-functional roles. She additionally serves on the boards of MetLife, Inc., Vertex Pharmaceuticals, Change Healthcare, Paradox, and is a particular advisor to Brighton Park Capital. Ms. McKenzie has been an energetic chief in numerous commerce, know-how and authorities organizations and has been acknowledged by the National Diversity Council as one of the nation’s Most Powerful Women in Technology. She is on the Forever Influential Women’s checklist on the San Francisco Business Times. Ms. McKenzie has a B.S. in Computer Information Systems and Computer Technology from Purdue University.
Fredrik Eliasson brings over 25 years of govt and senior management expertise. Mr. Eliasson is the manager vice chairman and chief monetary officer of Change Healthcare, a healthcare know-how firm that provides software program, analytics, community options, and technology-enabled companies. Previously, Mr. Eliasson was at CSX Corporation the place he held numerous management roles, together with govt vice chairman and chief gross sales and advertising and marketing officer, chief monetary officer, director of investor relations, and vice chairman of rising markets. Mr. Eliasson acquired an M.B.A. and a B.A. from Virginia Commonwealth University.
Loretta Cecil brings 36 years of authorized and compliance management to GenapSys, with a variety of confirmed experience in company governance. Previously, Ms. Cecil was senior vice chairman, governance relations at McKesson Corporation the place she supported McKesson’s board on shareholder outreach, and in addition was common counsel for McKesson Technology Solutions. Prior to becoming a member of McKesson, Ms. Cecil was common counsel and chief compliance officer for NCR Corporation’s retail division. Prior to that, she was a member of Womble Carlyle Sandridge & Rice LLP., and in addition held a number of senior positions inside AT&T. Currently, Ms. Cecil is the manager vice chairman and common counsel for Change Healthcare. Ms. Cecil acquired her J.D. with honors from The University of North Carolina at Chapel Hill and graduated magna cum laude with a B.A. in Political Science and Communication Studies from the University of North Carolina at Greensboro.
About GenapSys, Inc.
GenapSys is an organization centered on the development of common entry to genomic info by delivering an inexpensive, scalable, and correct genomic sequencing ecosystem that empowers each educational and medical analysis functions. Its system leverages a proprietary electrical microfluidic sequencing chip with a scalable quantity of detectors, permitting for a variety of functions. GenapSys is headquartered in Redwood City, CA.
GenapSys merchandise are supplied for Research Use Only. Not to be used in diagnostic procedures.
For Media Inquiries:
Surekha Karudapuram, VP, Product Management and Marketing
For Investor Inquiries:
David Deuchler, CFA
Managing Director |Gilmartin Group